Welcome to our dedicated page for CENTENE SEC filings (Ticker: CNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CENTENE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CENTENE's regulatory disclosures and financial reporting.
Centene Corporation’s Chief People Officer Tanya M. McNally had 964 shares of common stock withheld on April 15, 2026 to cover tax obligations when previously granted restricted stock units vested at a price of $37.26 per share. After this tax-withholding disposition, she holds 127,258 shares directly, including 112,054 restricted and performance stock units that remain subject to vesting requirements.
Centene Corp director Kenneth Tanji reported receiving a grant of 1,179 shares of Common Stock as a compensation-related award. The shares were acquired at no purchase price, increasing his direct holdings to 7,917 shares. Ownership includes 3,579 restricted stock units that are subject to vesting requirements.
Samuels Theodore R. II reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Theodore R. Samuels II received a grant of 943 shares of Common Stock as a stock award. The award was recorded at a price of $0.00 per share and increased his directly held stake to 20,755.979 shares.
He also has indirect ownership of 32,000 shares through a revocable family trust where he serves as co-trustee. Ownership further includes 3,579 shares of restricted stock units that are subject to vesting requirements.
EPPINGER FREDERICK H reported acquisition or exercise transactions in this Form 4 filing.
Centene Corporation director Frederick H. Eppinger reported receiving a grant of 1,690 shares of common stock, recorded at $0.00 per share as a compensation-related award, not an open-market purchase. Following this grant, he directly holds 362,050.658 common shares.
A footnote states that this ownership figure also includes 5,965 shares of restricted stock units that are subject to vesting requirements, meaning those shares will be delivered only if the vesting conditions are met.
COUGHLIN CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Christopher J. Coughlin received an equity award of 1,140 shares of common stock on March 31, 2026. The shares were granted at no cash cost as a stock-based compensation award, increasing his directly held common stock to 14,156.926 shares.
He also has indirect ownership of 30,054 shares held by a grantor retained annuity trust for the benefit of Mr. Coughlin and his adult children, where he serves as sole trustee. His direct ownership includes 3,579 restricted stock units that remain subject to vesting requirements.
Centene Corp executive Theodore J. Pienkos, Corporate Controller and Chief Accounting Officer, filed an initial ownership report showing 29,843.4930 shares of common stock held directly. This total includes 16,140 restricted stock units that vest in scheduled installments between September 15, 2026 and March 15, 2027.
The ownership also includes 1,381 performance stock units reported at target level, granted on March 15, 2024. The number of these performance units that will actually vest on March 15, 2027 can range from 0% to 200% of the target amount, depending on achievement of performance conditions.
Centene Corp: The Vanguard Group amends Schedule 13G to report zero beneficial ownership. The filing (Amendment No. 14) states amount beneficially owned: 0 and percent of class: 0% after an internal realignment; subsidiaries and business divisions will report separately in reliance on SEC Release No. 34-39538 (January 12, 1998).
Centene Corporation is asking stockholders to vote at its 2026 annual meeting on electing nine directors, approving executive pay on an advisory basis, ratifying KPMG as auditor, and a stockholder proposal the Board opposes.
The proxy highlights a challenging 2025, with total revenues of $194.8 billion, a diluted loss per share of $13.53 and adjusted diluted EPS of $2.08, as Medicaid volatility and a sicker Marketplace risk pool pressured results. Management describes corrective actions in pricing, risk management and portfolio focus across Medicaid, Medicare Advantage and Marketplace businesses.
Centene expects 2026 adjusted diluted EPS to exceed $3.00, implying more than 40% year-over-year growth, and points to double-digit improvements in key clinical metrics and strong call-center satisfaction scores. The Board emphasizes governance features such as annual director elections, majority voting, proxy access, a largely independent and refreshed board, and a pay-for-performance compensation design with rigorous stock ownership requirements.
Centene Corporation appointed Theodore Pienkos, 44, as Corporate Controller and Chief Accounting Officer effective March 18, 2026. He is a registered CPA and has served as Centene’s Deputy Corporate Controller since August 2024, after prior roles including Vice President of Finance & Accounting and earlier accounting positions at the company.
Before joining Centene in 2011, he worked as an auditor at KPMG LLP and holds BA and MA degrees in Accounting from the University of Northern Iowa. In his new role, he will receive a base salary of $440,000 and a target bonus of 60% of base salary, and will continue to participate in Centene’s incentive and executive severance programs.
The company also named Kate Casso, the prior Corporate Controller and Chief Accounting Officer, as Senior Vice President, Finance Operations and Innovation effective March 18, 2026, where she will focus on finance operations, data analytics, medical economics, payment integrity, and broader innovation initiatives.